Guidelines for cytogenetic investigations in tumours

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F16%3A10317950" target="_blank" >RIV/00064165:_____/16:10317950 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/16:10317950
Result on the web
<a href="http://dx.doi.org/10.1038/ejhg.2015.35" target="_blank" >http://dx.doi.org/10.1038/ejhg.2015.35</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/ejhg.2015.35" target="_blank" >10.1038/ejhg.2015.35</a>

Result language
angličtina
Original language name
Guidelines for cytogenetic investigations in tumours
Original language description
Cytogenetic and molecular genetic data are of paramount importance in the diagnosis, prognosis, and risk stratification of patients with malignant diseases. Sometimes they even directly guide the choice of therapy. Disease-specific abnormalities, particularly translocations, can provide essential information to assist the Pathologist and/or Oncologist in assigning a diagnosis. In several diseases, tumour genetics correlate strongly with clinical risk; thus, cytogenetic information may help the Oncologist counsel the patient, choose a specific treatment, and/or modulate treatment intensity. Clinical trials may involve cytogenetic classification of patients to the appropriate treatment regimens
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)